# Effect of Niacin in the Lipoprotein (a) Concentration

> **NCT01321034** · PHASE4 · COMPLETED · sponsor: **Instituto Aragones de Ciencias de la Salud** · enrollment: 90 (actual)

## Conditions studied

- Hypercholesterolemia

## Interventions

- **DRUG:** Niacin/Laropiprant

## Key facts

- **NCT ID:** NCT01321034
- **Lead sponsor:** Instituto Aragones de Ciencias de la Salud
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-08
- **Final completion:** 2012-12
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2013-01-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01321034

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01321034, "Effect of Niacin in the Lipoprotein (a) Concentration". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01321034. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*